The Europe dog dewormers market size is expected to reach USD 376.7 million in 2030 and is estimated to grow at a CAGR of 7.76% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising canine population coupled with their ownership and growing expenditure on dogs are major drivers propelling the market growth. FEDIAF’s 2022 report indicated that Europe’s pet-owning households reached 90 million (i.e. 46%) in 2021, and among these households live approximately 92.9 million dogs. Furthermore, the European population spends around USD 24.5 Billion on pet-related services and products each year, according to European Pet Food Industry. Similarly, according to data published by N26 GmbH in October 2020, around USD 15.8 to USD 52.8 (EUR 15-50) per month is spent on dog insurance, depending on their breed.

Various government organizations in Europe were actively monitoring the impact of COVID-19 on veterinary medicines supply chains. As per FVE (Federation of Veterinarians of Europe) in July 2021, veterinary services for companion animals in the region have been highly impacted during the mid of 2020, as only emergency and urgent treatments were allowed as per the government regulations. However, veterinary businesses quickly recovered with the support of e-commerce sales channels and the implementation of enormous government initiatives to continue veterinary healthcare practices.

For instance, in March 2020, FVE stated that veterinary services in Europe are considered one of the most essential businesses and will be continuing despite the ongoing pandemic. Veterinarians, vet clinics, and key market players have implemented various strategies to revive their services. Countries like the U.K. and France, have shifted towards digital vet consultations for essential pet care and proceeding with the online supply of dog dewormer products.

The Europe dog dewormers industry is expected to grow notably in the coming years. This can be attributed to the well-established veterinary care infrastructure, a large dog population, and the local presence of key companies. According to the annual report of FEDIAF 2022 (the European Pet Food Industry), the countries like Russia, the U.K., Germany, Spain, France, and Italy were registered to have households owning more than 7 million dogs.

The market is reasonably competitive. The most notable participants in the market include Merck & Co., Inc., Boehringer Ingelheim International GmbH, Ceva, Sava Healthcare, Beaphar, and Bob Martin, among others. These players are involved in acquisitions, new product launches, collaborations, geographical expansions, and partnerships to gain a competitive edge over each other. In January 2021, Boehringer Ingelheim International GmbH announced marketing authorization approval in Europe for NexGard products, which are used as antiparasitics in dogs and cats. The approval was granted by European Medicines Agency (EMA) and European Commission.

Europe Dog Dewormers Market Report Highlights

• By route of administration, the oral segment held the highest market share in 2024 and is anticipated to grow at the highest CAGR of 8.75% over the forecast period
• By dosage form, liquids held the highest share in 2024. This segment includes medications like semi-solid topical, oral, and injectable liquids.
• By type, the prescription segment dominated in terms of market share in 2024 and is expected to grow at the highest growth rate in the forecast period
• The veterinary hospitals/clinics segment is estimated to hold the largest market share of 40.08% in 2024 owing to the trust pet owners place in professional veterinary guidance for parasite control.
• The UK dog dewormers market is experiencing lucrative growth due to growing efforts to structure and upgrade regulatory guidelines surrounding veterinary medicines

Get a preview of the latest developments in the Europe Dog Dewormer Market? Download your FREE sample PDF copy today and explore key data and trends

Europe Dog Dewormers Market Segmentation

Grand View Research has segmented the Europe dog dewormers market on the basis of route of administration, dosage form, type, distribution channel, and country:

Europe Dog Dewormers Route of Administration Outlook (Revenue, USD Million; 2018 - 2030)

• Oral
• Injectable
• Topical

Europe Dog Dewormers Dosage Form Outlook (Revenue, USD Million; 2018 - 2030)

• Liquids
• Tablets

Europe Dog Dewormers Type Outlook (Revenue, USD Million; 2018 - 2030)

• OTC
• Prescription

Europe Dog Dewormers Distribution Channel Outlook (Revenue, USD Million; 2018 - 2030)

• Veterinary Hospitals/Clinics
• Retail/Pet Stores
• E-commerce

Europe Dog Dewormers Country Outlook (Revenue, USD Million; 2018 - 2030)

• Spain
• Germany
• Portugal
• Romania
• Slovakia
• Czech
• Hungary
• Poland
• Italy
• Ireland
• UK
• France
• Denmark
• Sweden
• Norway
• Rest of EU

Key Players in the Europe Dog Dewormers Market

• Zoetis
• Boehringer Ingelheim
• Merck & Co. Inc.
• Dechra Pharmaceuticals Plc.
• Elanco Animal Health
• Ceva Sante Animale
• ComVirbacp7
• Virbac
• Vetoquinol
• Bioveta, a.s.
• PetIQ, LLC

Order a free sample PDF of the Europe Dog Dewormer Market Intelligence Study, published by Grand View Research.